NDAINJECTIONINJECTABLE
Approved
Oct 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
XENON XE 133 (xenon xe-133) by Lantheus Medical Imaging is radiopharmaceutical activity [moa]. First approved in 1974.
Drug data last refreshed 16h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon XE-133 is a radioactive noble gas radiopharmaceutical administered by inhalation or injection for diagnostic imaging of pulmonary and cerebral blood flow. It functions as a ventilation and perfusion imaging agent, allowing clinicians to visualize regional lung function and brain perfusion patterns. The drug works through radiopharmaceutical activity, emitting gamma radiation detectable by gamma cameras.
LOE Approaching
With LOE approaching and minimal Part D commercial data, this mature diagnostic agent is in sustained-care mode; career growth likely limited to specialized nuclear medicine teams at Lantheus.
Mechanism of Action
Radiopharmaceutical Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Xenon XE-133 offers stable, specialized career development within diagnostic imaging and nuclear medicine—a deep niche rather than a growth market. This role suits professionals seeking operational leadership, regulatory expertise, or long-term portfolio stewardship in established products rather than launch excitement or expansion upside.
Product Manager (Diagnostics)Medical Science Liaison (Nuclear Medicine)
Worked on XENON XE 133 at Lantheus Medical Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.